Robert Barry - Co-Founder, Chairman

Robert has spent over 25 years in the medical device industry with extensive experience building and motivating premier product development teams.  He has a track record of successfully leading efforts to design, develop and commercialize novel products that make a difference in the lives of patients.   He has been involved with founding three medical device companies, including Stasys Medical Corp. which he co-founded in 2013.  Prior to Stasys Medical Corp., Robert founded Uptake Medical Corp., a medical device company that treats lung disease, securing funding from tier 1 Venture Capital Firms. He served as CEO through seed and Series A funding before transitioning to CTO and leading the project team through development and subsequent US and international clinical trials. Uptake Medical has raised over $70 million dollars and is in the early stages of successful commercialization.  Prior to Uptake Medical Corp., Robert co-founded CoAptus Medical Corp. and was instrumental in securing an agreement for purchase with Boston Scientific Corp.   Prior to CoAptus, Robert built and led the product development team for Spiration Inc. as Director of Product Development (Spiration Inc. was acquired by Olympus in 2010). Bob’s experience also includes working for world-class companies Boston Scientific Corp, Pfizer, and Bausch & Lomb.  Robert holds a Bachelor’s degree in Engineering from Rochester Institute of Technology (RIT) and has over 25 issued patents in the fields of cardiology, radiology, and pulmonology.

Ari Karchin, Ph.D. - Director of Operations

Ari has spent over 15 years as a design engineer and scientific researcher in the fields of tissue engineering, biomechanics, and hematology.  His experience includes project management, experimental design, test fixture design and fabrication, product development and technology transfer. He has been the Principal Investigator on 3 major commercialization grants, and has been key personnel on numerous scientific feasibility grants. Ari holds a PhD in Bioengineering from the University of Washington and MS and BS degrees in Biomedical Engineering and Mechanical Engineering, respectively, from the University of California, Davis. In addition, Ari holds a certificate in Medical Devices & Commercialization from the University of Washington.

Lucas Ting, Ph.D. - Director of Research & Development

Lucas is a multidisciplinary engineer and scientist whose dissertation research and work in platelet force sensing enables extremely rapid blood coagulation measurements, which forms the core of Stasys Medical’s technology.  His PhD dissertation on endothelial and platelet forces was recognized with the 2013 Innovation in Technology Award by the Western Association of Graduate Schools. Previously, Lucas worked at Procter & Gamble as a research engineer for polymer web processing. Lucas holds a Bachelor’s degree in mechanical engineering from the University of Illinois and a Master’s and PhD in mechanical engineering from the University of Washington.  While attending the University of Washington, Lucas was a NIH Bioengineering training grantee. Lucas has multiple publications and patents in the fields of bioreactors and mechanical cell sensing systems. 

Annie Smith - Research Scientist & Laboratory Manager

Prior to joining Stasys Medical, Annie was a Research Scientist and Lab Manager at the University of Washington working in conjunction with the Cell Biomechanics Laboratory, developing and conducting protocols with IRB authorization.  Annie manages the Stasys laboratory, conducts testing and assists in the development of microcards.  Annie holds a BS in Biochemistry from the University of Missouri, where she was a Research Specialist and published on in vitro vasculogenesis in collagen and fibrin matrices. 

Nate Sniadecki, Ph.D. - Co-Founder & Acting CTO

Nate Sniadecki is a leader in the field of cell mechanics and an expert in the use of engineering and nanotechnology for understanding the mechano-biology of cells. He joined the University of Washington as an Assistant Professor in Mechanical Engineering in 2007 and was promoted to Associate Professor in 2013. Prof. Sniadecki is a recipient of an NSF CAREER award in 2009 and a DARPA Young Faculty Award in 2011. As part of the DARPA award, Prof. Sniadecki developed the microfluidic-micropost device that is the basis of Stasys Medical’s technology, with follow-on funding from the Coulter Foundation, CoMotion, Life Science Discovery Fund, Washington Research Foundation, and the Institute of Translational Health Sciences. Prof. Sniadecki is the faculty mentor for Thomas Larson, founder of Micro Phone Lens, which is a flexible, silicone microscope lens for mobile phones. Prof. Sniadecki received his B.S. in Mechanical Engineering from the University of Notre Dame and his Ph.D. in Mechanical Engineering from the University of Maryland with Prof. Don DeVoe. He was a NIH NRSA post-doctoral fellow in Biomedical Engineering at Johns Hopkins University and a Hartwell Fellow at the University of Pennsylvania in Bioengineering with Prof. Chris Chen. Prof. Sniadecki currently holds the Albert Kobayashi Professorship in Mechanical Engineering. 

Nathan White, MD - Co-Founder & Clinical Consultant

Nathan is an Assistant Professor of Emergency Medicine and Adjunct Professor of Mechanical and Bioengineering at the University of Washington. Dr. White is a graduate of Wayne State University School of Medicine, and completed training in Emergency Medicine at the University of Cincinnati. He then completed post-doctoral research training in hemostasis and critical injury at the Virginia Commonwealth University Reanimation Engineering Shock Center. Dr. White is a practicing physician at the Harborview Medical Center Emergency Department, the region’s only major trauma center, and conducts an active research program focused on hemostasis during critical illness and injury. 

Michael Rackley - Consultant

Michael is a C-Level medical device/pharmaceutical and biotechnology industry executive with 25 years of progressive leadership, general management and cross functional professional experience.  $2BB+ in total deal value and capital procurement, possessing significant global expertise in all facets of the medical device/pharmaceutical and biotechnology industries including commercial operations, product development, manufacturing supply chain and “go to market” strategy.

Previously Michael was COO of Norgenix, a wholly owned subsidiary of the JM Smith Corporation where he also served as a Senior Vice President of the Corporation. He was the architect and Implementer of the Norgenix business plan, infrastructure and the successful in-license of over a dozen Class II and Class III first-in-class/best-in-class medical device products.  Credited with the successful commercialization of all products, including pioneering FETAL ECG.  Execution of numerous co-marketing and co-distribution agreements with equity positions in addition to exclusive market authorization rights.  In-license and commercialization of small molecule and biologic drugs.  Developed three distinct business units, state-of-the art fetal monitoring, and revolutionary technology in assisted reproduction and a pharmaceutical specialty component. Established commercial intra-functional business across a global supply chain for all products.

Michael served as VP of Business development at Kurve Technology and was awarded the 2006 Global Business Development Award from Frost and Sullivan.  He held executive positions at EffRx, Inc an effervescent drug delivery company and management positions at BMS and AHP. Graduated from West Virginia University in 1988 with a major in Business and minor in engineering sciences, Michael is a 1998 distinguished alumni, is married to his wife Bev of 26 years and has two daughters.